COVID 19 PNEUMONIA. This code assigned to a disease diagnosis of COVID-19 confirmed by laboratory testing.
Conditions
Interventions
Intervention 1: Intervention group: In this group of patients, intravenous vitamin C is injected at a dose of 2 grams every 6 hours for five days. The manufacturer of this drug is Iran Daroupakhsh Com
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who have a positive corona pcr test. Patients over 18 years of age. Oxygen saturation should be below 93%. The patient's respiratory rate should be more than 30 per minute. Lung involvement in chest or CT scans of the lungs is more than 50 percent.
Exclusion criteria
Exclusion criteria: Allergy to vitamin C The patient's shortness of breath may be due to cardiac pulmonary edema Be pregnant or breastfeeding Have chronic kidney disease Be in diabetic ketoacidosis Have kidney stones
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of lung involvement in a CT scan: According to the radiologist, the appearance of lung involvement and the percentage of lung involvement are measured. Timepoint: Five days after receiving vitamin C intravenously. Method of measurement: According to the radiologist, the appearance of lung involvement and the extent of lung involvement are scoring. | — |
Secondary
| Measure | Time frame |
|---|---|
| Oxygen saturation rate of patients. Timepoint: Five days after receiving vitamin C intravenously. Method of measurement: Using an pulse oxymeter.;Respiratory rate of patients. Timepoint: Five days after receiving vitamin C intravenously. Method of measurement: Examination by a doctor.;Serum CRP level. Timepoint: Five days after receiving vitamin C intravenously. Method of measurement: Report by Laboratory.;Lymphopenia rate. Timepoint: Five days after receiving vitamin C intravenously. Method of measurement: Report by Laboratory.;Mortality rate. Timepoint: At the end of the patient's hospitalization. Method of measurement: report by doctor.;Duration of hospitalization. Timepoint: At the end of the patient's hospitalization. Method of measurement: Calculated by a physician.;Intubation rate. Timepoint: At the end of the study. Method of measurement: Calculated by the analyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamideh Moradi Shahr Babak
Shahid Beheshti University of Medical Sciences
Outcome results
None listed